Product Information
XADAGO 100 MG TABLET is a brand product labeled by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., priced at $36.3071 per EA under NDC 27505011130. Its NADAC has been published 306 times since Aug 19, 2020.
Strength
100 mg/1
NDC
27505011130
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SAFINAMIDE MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA207145On Market Since
5/8/2017
Pharmacological Classes
Price Statistics
The NADAC for XADAGO 100 MG TABLET has been published 306 times since Aug 19, 2020, and over the history we have for it it has risen 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.3071 per EA |
|---|---|
| All-time high | $36.5817 (Apr 10, 2024) |
| All-time low | $26.9383 (Aug 19, 2020) |
| 52-week high | $36.5326 |
| 52-week low | $36.3071 |
| Median price | $36.3743 |
| Average price | $34.1372 |
| Largest weekly change | +8.0% (Sep 15, 2021) |
| Weeks tracked | 306 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the safinamide mesylate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XADAGO 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XADAGO 100 MG TABLET, manufactured by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., is $36.3071 per EA (NDC 27505011130), effective Jun 24, 2026.
How has the price of XADAGO 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for XADAGO 100 MG TABLET has risen 34.8%. It has been tracked across 306 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for XADAGO 100 MG TABLET?
Since Aug 19, 2020, the NADAC for XADAGO 100 MG TABLET has ranged from a low of $26.9383 (Aug 19, 2020) to a high of $36.5817 (Apr 10, 2024), with a median of $36.3743 per EA.
Are there cheaper alternatives to XADAGO 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XADAGO 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures XADAGO 100 MG TABLET?
XADAGO 100 MG TABLET (NDC 27505011130) is labeled by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification